相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Original article: The prognostic value of including non-alcoholic fatty liver disease in the definition of metabolic syndrome
Clarissa Elysia Fu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis
Santo Colosimo et al.
LIVER INTERNATIONAL (2021)
Cardiovascular risk factors in non-alcoholic fatty liver disease
Hannes Hagstrom et al.
LIVER INTERNATIONAL (2019)
The metabolic syndrome - What is it and how should it be managed?
Peter M. Nilsson et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
Hannes Hagstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
R Kahn et al.
DIABETES CARE (2005)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
分享论文
